Pediatric Endocrinology Diabetes and Metabolism

Medium-chain acyl-CoA dehydrogenase deficiency in the neonatal period: a case report

Aleksandra Wądołowska 1
,
Magdalena Alicja Suda-Całus 1
,
Ewa Matylda Gulczyńska 1

  1. Department of Neonatology, Neonatal Intensive Care Unit and Neonatal Pathology, Polish Mother’s
    Memorial Hospital – Research Institute, Łódz, Poland

Pediatr Endocrinol Diabetes Metab 2026; 32 (3):

DOI: https://doi.org/10.5114/pedm.2026.163264
Online publish date: 2026/08/14
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Medium-chain acyl-CoA dehydrogenase deficiency (MCADD) is the most prevalent inherited disorder of fatty acid metabolism. The symptoms of MCADD typically present in infancy and may lead to adverse outcomes for the newborn, requiring urgent medical intervention. This study aimed to describe the pathogenetic mechanism, clinical presentation, diagnosis, and treatment through a case study of a newborn diagnosed with MCADD.

Keywords

medium-chain acyl-CoA dehydrogenase deficiency, inherited disorders of fatty acid metabolism, neonatal hypoglycemia

SUBMIT YOUR PAPER
Share
without publication fees
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications